NORDIAZEPAM

Nordiazepam Adverse Events Reported to the FDA Over Time

How are Nordiazepam adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Nordiazepam, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Nordiazepam is flagged as the suspect drug causing the adverse event.

Most Common Nordiazepam Adverse Events Reported to the FDA

What are the most common Nordiazepam adverse events reported to the FDA?

Drug Toxicity	41 (6.79%)
Pulmonary Oedema	37 (6.13%)
Respiratory Depression	37 (6.13%)
Overdose	31 (5.13%)
Pulmonary Congestion	27 (4.47%)
Drug Interaction	25 (4.14%)
Completed Suicide	20 (3.31%)
Accidental Death	19 (3.15%)
Multiple Drug Overdose	19 (3.15%)
Accidental Overdose	15 (2.48%)
Accidental Poisoning	12 (1.99%)
	Show More
Pneumonia	10 (1.66%)
Asphyxia	9 (1.49%)
Cardiomegaly	9 (1.49%)
Brain Oedema	8 (1.32%)
Death	8 (1.32%)
Serotonin Syndrome	8 (1.32%)
Alcohol Poisoning	7 (1.16%)
Aspiration	7 (1.16%)
Snoring	7 (1.16%)
Bacterial Sepsis	6 (.99%)
Poisoning	6 (.99%)
Wrong Technique In Drug Usage Proce...	6 (.99%)
Arrhythmia	5 (.83%)
Bronchopneumonia	5 (.83%)
Hepatic Steatosis	5 (.83%)
Hepatitis C	5 (.83%)
Aggression	4 (.66%)
Cardiac Arrest	4 (.66%)
Drug Abuse	4 (.66%)
Encephalitis	4 (.66%)
Fall	4 (.66%)
Intentional Overdose	4 (.66%)
Loss Of Consciousness	4 (.66%)
Multiple Drug Overdose Accidental	4 (.66%)
Needle Track Marks	4 (.66%)
Stupor	4 (.66%)
Toxicologic Test Abnormal	4 (.66%)
Unresponsive To Stimuli	4 (.66%)
Vomiting	4 (.66%)
Cognitive Disorder	3 (.5%)
Congestive Cardiomyopathy	3 (.5%)
Contusion	3 (.5%)
Depression	3 (.5%)
Drug Screen Positive	3 (.5%)
Pneumonia Aspiration	3 (.5%)
Renal Failure	3 (.5%)
Respiratory Arrest	3 (.5%)
Sleep Paralysis	3 (.5%)
Accidental Exposure	2 (.33%)
Arteriosclerosis Coronary Artery	2 (.33%)
Blood Alcohol Increased	2 (.33%)
Cardio-respiratory Arrest	2 (.33%)
Drug Intolerance	2 (.33%)
Drug Level Increased	2 (.33%)
Excoriation	2 (.33%)
Hypothermia	2 (.33%)
Myocardial Ischaemia	2 (.33%)
Pneumoconiosis	2 (.33%)
Road Traffic Accident	2 (.33%)
Sleep Apnoea Syndrome	2 (.33%)
Somnolence	2 (.33%)
Spleen Congestion	2 (.33%)
Sudden Death	2 (.33%)
Visceral Congestion	2 (.33%)
Abnormal Behaviour	1 (.17%)
Acute Pulmonary Oedema	1 (.17%)
Agitation	1 (.17%)
Alcohol Use	1 (.17%)
Anuria	1 (.17%)
Aortic Arteriosclerosis	1 (.17%)
Aortic Valve Calcification	1 (.17%)
Aortic Valve Stenosis	1 (.17%)
Aspartate Aminotransferase Increase...	1 (.17%)
Asthma	1 (.17%)
Blood Glucose Increased	1 (.17%)
Blood Ph Increased	1 (.17%)
Blood Pressure Decreased	1 (.17%)
Blood Pressure Systolic Decreased	1 (.17%)
Bone Fissure	1 (.17%)
Brain Injury	1 (.17%)
Bronchiolitis	1 (.17%)
Cachexia	1 (.17%)
Cerebrovascular Disorder	1 (.17%)
Chest Injury	1 (.17%)
Condition Aggravated	1 (.17%)
Continuous Positive Airway Pressure	1 (.17%)
Coronary Artery Disease	1 (.17%)
Cyanosis	1 (.17%)
Dehydration	1 (.17%)
Dependence	1 (.17%)
Dialysis	1 (.17%)
Drug Dependence	1 (.17%)
Drug Effect Decreased	1 (.17%)
Drug Ineffective	1 (.17%)
Drug Level Below Therapeutic	1 (.17%)
Ecchymosis	1 (.17%)
Eschar	1 (.17%)
Exposure To Toxic Agent	1 (.17%)
Eye Haemorrhage	1 (.17%)
Foaming At Mouth	1 (.17%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Nordiazepam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Nordiazepam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Nordiazepam

What are the most common Nordiazepam adverse events reported to the FDA?

Medication Errors	82 (13.58%)
Chemical Injury And Poisoning	70 (11.59%)
Lower Respiratory Tract Disorders	68 (11.26%)
Respiratory	67 (11.09%)
Fatal Outcomes	30 (4.97%)
Therapeutic And Nontherapeutic Effe...	29 (4.8%)
Infections - Pathogen Unspecified	21 (3.48%)
Suicidal And Self-injurious Behavio...	21 (3.48%)
Injuries	17 (2.81%)
Neurological	15 (2.48%)
Myocardial	13 (2.15%)
	Show More
Cardiac Arrhythmias	12 (1.99%)
Toxicology And Therapeutic Drug Mon...	12 (1.99%)
Hepatic And Hepatobiliary	8 (1.32%)
Increased Intracranial Pressure And...	8 (1.32%)
Neuromuscular	8 (1.32%)
Psychiatric	7 (1.16%)
Coronary Artery	6 (.99%)
Viral Infectious	6 (.99%)
Epidermal And Dermal Conditions	5 (.83%)
Gastrointestinal Signs	5 (.83%)
Central Nervous System Infections A...	4 (.66%)
Mental Impairment	4 (.66%)
Personality Disorders	4 (.66%)
Renal Disorders	4 (.66%)
Cardiac And Vascular Investigations	3 (.5%)
Depressed Mood Disorders	3 (.5%)
Sleep Disturbances	3 (.5%)
Body Temperature Conditions	2 (.33%)
Cardiac Disorder Signs	2 (.33%)
Cardiac Valve	2 (.33%)
Gastrointestinal Conditions	2 (.33%)
Gastrointestinal Ulceration And Per...	2 (.33%)
Joint	2 (.33%)
Legal Issues	2 (.33%)
Lifestyle Issues	2 (.33%)
Metabolic, Nutritional And Blood Ga...	2 (.33%)
Muscle	2 (.33%)
Physical Examination Topics	2 (.33%)
Spleen, Lymphatic And Reticulendoth...	2 (.33%)
Therapeutic Procedures And Supporti...	2 (.33%)
Urinary Tract Signs	2 (.33%)
Acid-base	1 (.17%)
Administration Site Reactions	1 (.17%)
Anxiety Disorders	1 (.17%)
Appetite And General Nutritional	1 (.17%)
Arteriosclerosis, Stenosis, Vascula...	1 (.17%)
Bacterial Infectious	1 (.17%)
Bone And Joint Injuries	1 (.17%)
Bronchial Disorders	1 (.17%)
Central Nervous System Vascular	1 (.17%)
Cornification And Dystrophic Skin	1 (.17%)
Disturbances In Thinking	1 (.17%)
Electrolyte And Fluid Balance Condi...	1 (.17%)
Exocrine Pancreas Conditions	1 (.17%)
Gastrointestinal Hemorrhages	1 (.17%)
Glucose Metabolism Disorders	1 (.17%)
Hematological And Lymphoid Tissue T...	1 (.17%)
Hematology Investigations	1 (.17%)
Hepatobiliary	1 (.17%)
Investigations, Imaging And Histopa...	1 (.17%)
Musculoskeletal And Connective Tiss...	1 (.17%)
Musculoskeletal And Connective Tiss...	1 (.17%)
Ocular Hemorrhages And Vascular	1 (.17%)
Pleural	1 (.17%)
Product Quality Issues	1 (.17%)
Psychiatric And Behavioural Symptom...	1 (.17%)
Respiratory Tract Therapeutic Proce...	1 (.17%)
Skin Vascular Abnormalities	1 (.17%)
Sleep Disorders	1 (.17%)
Structural Brain	1 (.17%)
Tongue Conditions	1 (.17%)
Upper Respiratory Tract Disorders	1 (.17%)
Vascular Hemorrhagic	1 (.17%)
Venous Varices	1 (.17%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Nordiazepam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Nordiazepam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.